🇺🇸 FDA
Patent

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 8703150 (Methods of using Bacillus anthracis protective antigen sequences for vaccination) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K39/00, A61P